Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0013421 (
dystonia
)
8,418
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hypoparathyroidism leading to status dystonicus is rarely reported in literature. The authors present an 8-y-old girl with idiopathic familial hypoparathyroidism who presented with status dystonicus. She was managed successfully with midazolam infusion, calcium and
vitamin D
supplementation, and oral anti-
dystonia
drugs.
...
PMID:Status Dystonicus in a Child with Familial Idiopathic Hypoparathyroidism. 2816 Jan 54
Dyskinesia refers to any involuntary movement, such as chorea,
dystonia
, ballism that affect any part of the body. Levodopa-induced dyskinesia is a neurological disorder that afflicts many patients with Parkinson disease usually 5 years after the onset of levodopa therapy and can cause severe disability. The pathophysiology of this dyskinesia is complex and not fully understood. However, the association between
vitamin D
and Parkinson disease is interesting. The present study was conducted to evaluate the effect of
vitamin D
on levodopa induced dyskinesia in patients with Parkinson's disease .In this Double blind clinical trial, 120 patients with PD divided into two groups randomly,
vitamin D
and placebo group. A dose of 1000 IU/d was selected, Demographic information is registered. In the first visit, three variables have been measured which were the duration, severity of dyskinesia and unified Parkinson's disease rating scale (UPDRS). These variables were measured again after 3 months and the data was analyzed using SPSS 22. There are no differences between two groups after 3 months. This study revealed,
vitamin D
has no effects on improvement of levodopa induced dyskinesia.
...
PMID:Treatment of Levodopainduced dyskinesia with Vitamin D: A Randomized, double-blind, placebo-controlled trial. 3037 40